Cargando…

Predictive Testing of Early CIN Behaviour by Molecular Biomarkers

Detalles Bibliográficos
Autores principales:	Baak, Jan P. A., Kruse, Arnold-Jan, Janssen, Emiel, van Diermen, Bianca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2005
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615945/ https://www.ncbi.nlm.nih.gov/pubmed/16373961 http://dx.doi.org/10.1155/2005/808654

Ejemplares similares

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Baak, Jan P. A., et al.
Publicado: (2005)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Kruse, Arnold-Jan, et al.
Publicado: (2004)

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study
por: Munk, Ane Cecilie, et al.
Publicado: (2012)

A protein profile study to discriminate CIN lesions from normal cervical epithelium
por: Uleberg, Kai-Erik, et al.
Publicado: (2011)

Quantitative Histopathological Analysis of CIN Sections
por: Baak, Jan P. A.
Publicado: (2006)

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer
por: Lillesand, Melinda, et al.
Publicado: (2020)

Prediction of Spontaneous Regression of Cervical Intraepithelial Neoplasia Lesions Grades 2 and 3 by Proteomic Analysis
por: Uleberg, Kai-Erik, et al.
Publicado: (2014)

The Relationship between Syntactic Structure Analysis Features, Histological Grade and High-Risk HPV DNA in Cervical Intraepithelial Neoplasia
por: Kruse, Arnold‐Jan, et al.
Publicado: (2004)

Up to your NEK2 in CIN
por: Seachrist, Darcie D., et al.
Publicado: (2021)

Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies
por: Uleberg, Kai-Erik, et al.
Publicado: (2011)

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019)

The Ed. Ef Cin. Med. Jour. Remarks
Publicado: (1889)

The wages of CIN
por: Yuen, Karen W., et al.
Publicado: (2008)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

Iso-osmolar Iodixanol Is Better than Low-osmolar Contrast for CIN Prevention. And Then?
por: Jo, Sang-Ho
Publicado: (2021)

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival
por: Halle, Mari K., et al.
Publicado: (2021)

Correlation of Grade of Urothelial Cell Carcinomas and DNA Histogram Features Assessed by Flow Cytometry and Automated Image Cytometry
por: Bol, Marco G. W., et al.
Publicado: (2003)

High Frequency Microsatellite Instability Has a Prognostic Value in Endometrial Endometrioid Adenocarcinoma, But Only in FIGO Stage 1 Cases
por: Steinbakk, Anita, et al.
Publicado: (2010)

High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling
por: Øvestad, Irene Tveiterås, et al.
Publicado: (2021)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Silvestrini, Rosella
Publicado: (2005)

Preseason aerobic and anaerobic tests for prediction of alpine skiing performance: a molecular perspective
por: Koller, Arnold, et al.
Publicado: (2019)

Tincture Cin Honœ Ferrata
por: Sims, Samuel
Publicado: (1853)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

Biomarkers for Early Detection of Cancer: Molecular Aspects
por: Tappia, Paramjit S., et al.
Publicado: (2023)

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
por: Mariani, Luciano, et al.
Publicado: (2016)

A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells
por: Lee, Hee-Sheung, et al.
Publicado: (2013)

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
por: Austin, R. Marshall, et al.
Publicado: (2020)

Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2–3
por: Munk, Ane Cecilie, et al.
Publicado: (2012)

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
por: Engesæter, Birgit, et al.
Publicado: (2016)

Quantitative Histopathological Analysis of CIN Sections
por: Guillaud, Martial, et al.
Publicado: (2006)

Evolution of aneuploidy: overcoming the original CIN
por: Storchova, Zuzana
Publicado: (2018)

The adaptive strategies of cells in the face of CIN
por: Storchová, Zuzana
Publicado: (2023)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

Overexpression of programmed cell death ligand 1 in patients with CIN and its correlation with human papillomavirus infection and CIN persistence
por: Sancakli Usta, Ceyda, et al.
Publicado: (2020)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Toward Molecular Medicine in Female Infertility Management: Editorial to the Special Issue “Molecular Mechanisms of Human Oogenesis and Early Embryogenesis”
por: Tesarik, Jan
Publicado: (2021)

p53 hides a multitude of CIN
por: Short, Ben
Publicado: (2010)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

The Regulation of CIN-like TCP Transcription Factors
por: Lan, Jingqiu, et al.
Publicado: (2020)

Apoptosis as a Barrier against CIN and Aneuploidy
por: Weiss, Johannes G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_puhv5sbdds7ujjn83a40fj7avm